Squarepoint’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.41M | Buy |
|
|||||
|
2025
Q2 | $6.48M | Sell |
|
|||||
|
2025
Q1 | $5.74M | Buy |
|
|||||
|
2024
Q4 | $2.71M | Buy |
|
|||||
|
2024
Q3 | $108K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $496K | Sell |
|
|||||
|
2023
Q4 | $1.92M | Sell |
|
|||||
|
2023
Q3 | $5.28M | Buy |
|
|||||
|
2023
Q2 | $139K | Sell |
|
|||||
|
2023
Q1 | $1.26M | Sell |
|
|||||
|
2022
Q4 | $3.19M | Buy |
|
|||||
|
2022
Q3 | $2.19M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $4.93M | Buy |
|
|||||
|
2021
Q4 | $670K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $577K | Buy |
|
|||||
|
2020
Q4 | $165K | Buy |
|
|||||
|
2020
Q3 | $39K | Sell |
|
|||||
|
2020
Q2 | $405K | Sell |
|
|||||
|
2020
Q1 | $175K | Sell |
|
|||||
|
2019
Q4 | $2.13M | Buy |
|
|||||
|
2019
Q3 | $1.02M | Buy |
|
|||||
|
2019
Q2 | $163K | Sell |
|
|||||
|
2019
Q1 | $914K | Buy |
|
|||||
|
2018
Q4 | $381K | Sell |
|
|||||
|
2018
Q3 | $462K | Sell |
|
|||||
|
2018
Q2 | $720K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $343K | Buy |
|
|||||
|
2017
Q2 | $195K | Buy |
|
|||||
|
2017
Q1 | $141K | Sell |
|
|||||
|
2016
Q4 | $224K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $117K | Buy |
|
|||||
|
2015
Q4 | $281K | Buy |
|